Enliven Therapeutics Inc (ELVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2017 | 12-2006 | 12-2005 | 12-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -23,463 | N/A | N/A | N/A | 20,560 |
| Depreciation Amortization | 14 | N/A | N/A | N/A | 3,740 |
| Accounts payable and accrued liabilities | 750 | N/A | N/A | N/A | N/A |
| Other Working Capital | 673 | N/A | N/A | N/A | -1,820 |
| Other Operating Activity | 149 | 0 | 0 | 0 | -20,200 |
| Operating Cash Flow | $-21,877 | $N/A | $N/A | $N/A | $2,280 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -23,920 | N/A | N/A | N/A | N/A |
| PPE Investments | -140 | N/A | N/A | N/A | -1,640 |
| Net Acquisitions | N/A | N/A | N/A | N/A | 15,060 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -7,320 |
| Investing Cash Flow | $-24,060 | $N/A | $N/A | $N/A | $6,100 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 43,579 | 0 | 0 | 0 | 90 |
| Financing Cash Flow | $43,579 | $N/A | $N/A | $N/A | $90 |
| Beginning Cash Position | 7,382 | N/A | N/A | N/A | 4,580 |
| End Cash Position | 5,024 | N/A | N/A | N/A | 13,060 |
| Net Cash Flow | $-2,358 | $N/A | $N/A | $N/A | $8,470 |
| Free Cash Flow | |||||
| Operating Cash Flow | -21,877 | N/A | N/A | N/A | 2,280 |
| Capital Expenditure | -140 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -22,017 | 0 | 0 | 0 | 2,280 |